HIG Capital exits Celerion in $1.8bn sale
Tuesday, June 16, 2026 · first reported by Private Equity Wire
HIG Capital completed $1.8bn sale of clinical research organization Celerion to THL Partners funds, marking Advantage fund realization.
- Firm
- HIG Capital
- Also named
- THL Partners, Celerion Holdings
- Fund
- Advantage
- Deal value
- $1.8B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on HIG Capital
Everything on this firm →More in Deals
From the same day- Altor, Strawberry, TDR Capital to exit of Nordic Leisure Travel Group for $846mPE Hub
- LondonMetric and Schroder Real Estate close in on £396m Picton dealInvestment Week
- Francisco Partners acquires EfficientIPPE Hub
- Cathay Capital acquires majority stake in product data SaaS firm EquadisPE Hub
- EQT’s massive sustainability-linked credit facility leans into materialityNew Private Markets
- Teleo-backed Flatirons acquires enterprise AI platform Scope ARPE Hub